Related Experiment Video

Updated: Jun 14, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

A cause of failure in sympathectomy?

H A HAXTON

    Lancet (London, England)
    |March 27, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    SYMPATHECTOMY/failure

    More Related Videos

    Surgical Lumbar Sympathectomy in Mice
    05:24

    Surgical Lumbar Sympathectomy in Mice

    Published on: July 5, 2024

    A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
    12:40

    A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

    Published on: September 28, 2022

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
    03:59

    Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

    Published on: January 10, 2019

    Surgical Lumbar Sympathectomy in Mice
    05:24

    Surgical Lumbar Sympathectomy in Mice

    Published on: July 5, 2024

    A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
    12:40

    A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

    Published on: September 28, 2022

    Related Concept Videos

    Healing II: Complications01:24

    Healing II: Complications

    Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

    Articles linked to this work by shared authors, journal, and citation graph.

    Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

    Lancet (London, England)·2026

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

    Lancet (London, England)·2026

    [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

    Lancet (London, England)·2026

    Cardiac Autonomic Modulation in Seizure Disorders With and Without Interictal Epileptiform Discharges: A Retrospective Heart Rate Variability Analysis Using Archived Digital EEG Recordings.

    Cureus·2026

    Dynamics in Pro-Inflammatory Cytokines in Response to Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea.

    Laryngoscope investigative otolaryngology·2026

    Non-Aneurysmal Subarachnoid Hemorrhage in a Patient With Type 1 Diabetes Mellitus: A Case Report.

    Cureus·2026

    Phenothiazine-tetrazole hybrids as potent cholinesterase inhibitors: Integrated experimental and computational insights for Alzheimer's therapy.

    Bioorganic chemistry·2026

    ASSESSMENT OF SUBCLINICAL RENAL INSULT IN SHORT- AND LONG-TERM UNCONTROLLED HYPERTENSION USING MOLECULAR BIOMARKERS OF NGAL AND KIM-1.

    Georgian medical news·2026

    Sabinene attenuates inflammation and oxidative stress in CFA-induced arthritis: In vivo and in silico evidence implicating TLR4/NLRP3/NF-κB signaling.

    Biomolecules & biomedicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us